Industry Research Reports
Home > Reports > Medical Care > Global Sickle Cell Disease Diagnosis and Treatment Market Insights, Forecast to 2030
Global Sickle Cell Disease Diagnosis and Treatment Market Insights, Forecast to 2030
Industry: Medical Care
Published Date: 2024-04-15
Pages: 111 Pages
Report ld: 2845357
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Market Analysis and Insights: Global Sickle Cell Disease Diagnosis and Treatment Market
The global Sickle Cell Disease Diagnosis and Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Sickle Cell Disease Diagnosis and Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sickle Cell Disease Diagnosis and Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sickle Cell Disease Diagnosis and Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sickle Cell Disease Diagnosis and Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sickle Cell Disease Diagnosis and Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sickle Cell Disease Diagnosis and Treatment revenue, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Emmaus Medical
- Addmedica
- Gamida Cell
- GlycoMimetics
- Pfizer
- Novartis
- Global Blood Therapeutics
- Micelle BioPharma
- Bluebird Bio
- Prolong Pharmaceuticals
- Modus Therapeutics
- Sangamo Biosciences
- Bioverativ
- Imara
- Ironwood Pharmaceuticals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Diagnosis
- Treatment
Segment by Application
- Child
- Adult
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Perspective (2019-2030)
2.2 Global Sickle Cell Disease Diagnosis and Treatment Growth Trends by Region
2.2.1 Sickle Cell Disease Diagnosis and Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Region (2019-2024)
2.2.3 Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Region (2025-2030)
2.3 Sickle Cell Disease Diagnosis and Treatment Market Dynamics
2.3.1 Sickle Cell Disease Diagnosis and Treatment Industry Trends
2.3.2 Sickle Cell Disease Diagnosis and Treatment Market Drivers
2.3.3 Sickle Cell Disease Diagnosis and Treatment Market Challenges
2.3.4 Sickle Cell Disease Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sickle Cell Disease Diagnosis and Treatment by Players
3.1.1 Global Sickle Cell Disease Diagnosis and Treatment Revenue by Players (2019-2024)
3.1.2 Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Sickle Cell Disease Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Sickle Cell Disease Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Diagnosis and Treatment Revenue in 2023
3.5 Global Key Players of Sickle Cell Disease Diagnosis and Treatment Head office and Area Served
3.6 Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Product and Application
3.7 Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Diagnosis and Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Type (2019-2024)
4.2 Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Type (2025-2030)
5 Sickle Cell Disease Diagnosis and Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Application (2019-2024)
5.2 Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
6.2 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Type
6.2.1 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024)
6.2.2 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030)
6.2.3 North America Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
6.3 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Application
6.3.1 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024)
6.3.2 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030)
6.3.3 North America Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
6.4 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country
6.4.1 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024)
6.4.3 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
7.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Type
7.2.1 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024)
7.2.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030)
7.2.3 Europe Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
7.3 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Application
7.3.1 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024)
7.3.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030)
7.3.3 Europe Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
7.4 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country
7.4.1 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024)
7.4.3 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
8.2 China Sickle Cell Disease Diagnosis and Treatment Market Size by Type
8.2.1 China Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024)
8.2.2 China Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030)
8.2.3 China Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
8.3 China Sickle Cell Disease Diagnosis and Treatment Market Size by Application
8.3.1 China Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024)
8.3.2 China Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030)
8.3.3 China Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
9.2 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Type
9.2.1 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024)
9.2.2 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030)
9.2.3 Asia Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
9.3 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Application
9.3.1 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024)
9.3.2 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030)
9.3.3 Asia Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
9.4 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Region
9.4.1 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2019-2024)
9.4.3 Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Details
11.1.2 Emmaus Medical Business Overview
11.1.3 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Introduction
11.1.4 Emmaus Medical Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.1.5 Emmaus Medical Recent Developments
11.2 Addmedica
11.2.1 Addmedica Company Details
11.2.2 Addmedica Business Overview
11.2.3 Addmedica Sickle Cell Disease Diagnosis and Treatment Introduction
11.2.4 Addmedica Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.2.5 Addmedica Recent Developments
11.3 Gamida Cell
11.3.1 Gamida Cell Company Details
11.3.2 Gamida Cell Business Overview
11.3.3 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Introduction
11.3.4 Gamida Cell Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.3.5 Gamida Cell Recent Developments
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Details
11.4.2 GlycoMimetics Business Overview
11.4.3 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Introduction
11.4.4 GlycoMimetics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.4.5 GlycoMimetics Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Sickle Cell Disease Diagnosis and Treatment Introduction
11.5.4 Pfizer Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.5.5 Pfizer Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Sickle Cell Disease Diagnosis and Treatment Introduction
11.6.4 Novartis Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.6.5 Novartis Recent Developments
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Details
11.7.2 Global Blood Therapeutics Business Overview
11.7.3 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Introduction
11.7.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.7.5 Global Blood Therapeutics Recent Developments
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Details
11.8.2 Micelle BioPharma Business Overview
11.8.3 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Introduction
11.8.4 Micelle BioPharma Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.8.5 Micelle BioPharma Recent Developments
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Details
11.9.2 Bluebird Bio Business Overview
11.9.3 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Introduction
11.9.4 Bluebird Bio Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.9.5 Bluebird Bio Recent Developments
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Details
11.10.2 Prolong Pharmaceuticals Business Overview
11.10.3 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Introduction
11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.10.5 Prolong Pharmaceuticals Recent Developments
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Details
11.11.2 Modus Therapeutics Business Overview
11.11.3 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Introduction
11.11.4 Modus Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.11.5 Modus Therapeutics Recent Developments
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Details
11.12.2 Sangamo Biosciences Business Overview
11.12.3 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Introduction
11.12.4 Sangamo Biosciences Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.12.5 Sangamo Biosciences Recent Developments
11.13 Bioverativ
11.13.1 Bioverativ Company Details
11.13.2 Bioverativ Business Overview
11.13.3 Bioverativ Sickle Cell Disease Diagnosis and Treatment Introduction
11.13.4 Bioverativ Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.13.5 Bioverativ Recent Developments
11.14 Imara
11.14.1 Imara Company Details
11.14.2 Imara Business Overview
11.14.3 Imara Sickle Cell Disease Diagnosis and Treatment Introduction
11.14.4 Imara Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.14.5 Imara Recent Developments
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Details
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.15.5 Ironwood Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2019-2024)
Table 8. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2025-2030)
Table 10. Sickle Cell Disease Diagnosis and Treatment Market Trends
Table 11. Sickle Cell Disease Diagnosis and Treatment Market Drivers
Table 12. Sickle Cell Disease Diagnosis and Treatment Market Challenges
Table 13. Sickle Cell Disease Diagnosis and Treatment Market Restraints
Table 14. Global Sickle Cell Disease Diagnosis and Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Sickle Cell Disease Diagnosis and Treatment Revenue Share by Players (2019-2024)
Table 16. Global Top Sickle Cell Disease Diagnosis and Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Diagnosis and Treatment as of 2023)
Table 17. Global Sickle Cell Disease Diagnosis and Treatment Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Sickle Cell Disease Diagnosis and Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Headquarters and Area Served
Table 20. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Product and Application
Table 21. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Sickle Cell Disease Diagnosis and Treatment Revenue Share by Application (2019-2024)
Table 29. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Sickle Cell Disease Diagnosis and Treatment Revenue Share by Application (2025-2030)
Table 31. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Sickle Cell Disease Diagnosis and Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Sickle Cell Disease Diagnosis and Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Sickle Cell Disease Diagnosis and Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 63. Emmaus Medical Company Details
Table 64. Emmaus Medical Business Overview
Table 65. Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Product
Table 66. Emmaus Medical Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 67. Emmaus Medical Recent Developments
Table 68. Addmedica Company Details
Table 69. Addmedica Business Overview
Table 70. Addmedica Sickle Cell Disease Diagnosis and Treatment Product
Table 71. Addmedica Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 72. Addmedica Recent Developments
Table 73. Gamida Cell Company Details
Table 74. Gamida Cell Business Overview
Table 75. Gamida Cell Sickle Cell Disease Diagnosis and Treatment Product
Table 76. Gamida Cell Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 77. Gamida Cell Recent Developments
Table 78. GlycoMimetics Company Details
Table 79. GlycoMimetics Business Overview
Table 80. GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Product
Table 81. GlycoMimetics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 82. GlycoMimetics Recent Developments
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Sickle Cell Disease Diagnosis and Treatment Product
Table 86. Pfizer Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 87. Pfizer Recent Developments
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Sickle Cell Disease Diagnosis and Treatment Product
Table 91. Novartis Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 92. Novartis Recent Developments
Table 93. Global Blood Therapeutics Company Details
Table 94. Global Blood Therapeutics Business Overview
Table 95. Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Product
Table 96. Global Blood Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 97. Global Blood Therapeutics Recent Developments
Table 98. Micelle BioPharma Company Details
Table 99. Micelle BioPharma Business Overview
Table 100. Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Product
Table 101. Micelle BioPharma Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 102. Micelle BioPharma Recent Developments
Table 103. Bluebird Bio Company Details
Table 104. Bluebird Bio Business Overview
Table 105. Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Product
Table 106. Bluebird Bio Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 107. Bluebird Bio Recent Developments
Table 108. Prolong Pharmaceuticals Company Details
Table 109. Prolong Pharmaceuticals Business Overview
Table 110. Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product
Table 111. Prolong Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 112. Prolong Pharmaceuticals Recent Developments
Table 113. Modus Therapeutics Company Details
Table 114. Modus Therapeutics Business Overview
Table 115. Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Product
Table 116. Modus Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 117. Modus Therapeutics Recent Developments
Table 118. Sangamo Biosciences Company Details
Table 119. Sangamo Biosciences Business Overview
Table 120. Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Product
Table 121. Sangamo Biosciences Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 122. Sangamo Biosciences Recent Developments
Table 123. Bioverativ Company Details
Table 124. Bioverativ Business Overview
Table 125. Bioverativ Sickle Cell Disease Diagnosis and Treatment Product
Table 126. Bioverativ Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 127. Bioverativ Recent Developments
Table 128. Imara Company Details
Table 129. Imara Business Overview
Table 130. Imara Sickle Cell Disease Diagnosis and Treatment Product
Table 131. Imara Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 132. Imara Recent Developments
Table 133. Ironwood Pharmaceuticals Company Details
Table 134. Ironwood Pharmaceuticals Business Overview
Table 135. Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product
Table 136. Ironwood Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
Table 137. Ironwood Pharmaceuticals Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Type: 2023 VS 2030
Figure 3. Diagnosis Features
Figure 4. Treatment Features
Figure 5. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Application: 2023 VS 2030
Figure 7. Child Case Studies
Figure 8. Adult Case Studies
Figure 9. Sickle Cell Disease Diagnosis and Treatment Report Years Considered
Figure 10. Global Sickle Cell Disease Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Sickle Cell Disease Diagnosis and Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region: 2023 VS 2030
Figure 13. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Players in 2023
Figure 14. Global Top Sickle Cell Disease Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Diagnosis and Treatment as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Sickle Cell Disease Diagnosis and Treatment Revenue in 2023
Figure 16. North America Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
Figure 18. North America Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
Figure 19. North America Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2019-2030)
Figure 20. United States Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Sickle Cell Disease Diagnosis and Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 23. Europe Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
Figure 24. Europe Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
Figure 25. Europe Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2019-2030)
Figure 26. Germany Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. China Sickle Cell Disease Diagnosis and Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 33. China Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
Figure 34. China Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
Figure 35. Asia Sickle Cell Disease Diagnosis and Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 36. Asia Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
Figure 37. Asia Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
Figure 38. Asia Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2019-2030)
Figure 39. Japan Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. China Taiwan Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Share by Type (2019-2030)
Figure 47. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Share by Application (2019-2030)
Figure 48. Middle East, Africa, and Latin America Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2019-2030)
Figure 49. Brazil Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Mexico Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Turkey Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Israel Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. GCC Countries Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Emmaus Medical Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 56. Addmedica Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 57. Gamida Cell Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 58. GlycoMimetics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 59. Pfizer Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 60. Novartis Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 61. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 62. Micelle BioPharma Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 63. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 64. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 65. Modus Therapeutics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 66. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 67. Bioverativ Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 68. Imara Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 69. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Sickle Cell Disease Diagnosis and Treatment market?
The top companies in the global Sickle Cell Disease Diagnosis and Treatment market are Emmaus Medical、Addmedica、Gamida Cell.
Related Reports
Sickle Cell Disease Diagnosis and Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sickle Cell Disease Diagnosis and Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 105
USD 3950.00
(Single User License)
Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2025
The global market for Sickle Cell Disease Diagnosis and Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 85
USD 2900.00
(Single User License)
Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2024
The global Sickle Cell Disease Diagnosis and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 91
USD 2900.00
(Single User License)
Sickle Cell Disease Diagnosis and Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sickle Cell Disease Diagnosis and Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 105
USD 3950.00 (Single User License)Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2025
The global market for Sickle Cell Disease Diagnosis and Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 85
USD 2900.00 (Single User License)Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2024
The global Sickle Cell Disease Diagnosis and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now